TrialsgrambetaRCTs are beautiful

COMPASS

2017

Cardiovascular Outcomes for People Using Anticoagulation Strategies

In 27,395 patients with stable coronary or peripheral artery disease, low-dose rivaroxaban plus aspirin reduced cardiovascular death, stroke or MI compared with aspirin alone.

Result

Efficacy: CV death, stroke or MIHR 0.76

Below 1 favours low-dose rivaroxaban plus aspirin, above 1 favours aspirin alone.

Event rates
Absolute difference
1.3 points

The absolute difference is derived from the event rates.

Also reported: More major bleeding; all-cause mortality reduced.

Original publication
Subtopic
Chronic atherosclerosis
Design
Double-blind RCT, stopped early
Relevance
Important: one of several pillars.
Source
Eikelboom JW, et al. N Engl J Med. 2017;377(14):1319-1330.doi 10.1056/NEJMoa1709118

Discussion & critique

Dual-pathway inhibition for chronic atherosclerosis. The absolute benefit is modest and bleeding is increased, so it targets higher-ischaemic, lower-bleeding-risk patients.

Discussed in podcasts